FARALLON CAPITAL MANAGEMENT LLC 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:18 pm Sale | 2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | FARALLON CAPITAL MANAGEMENT LLC | 3,417,134 6.900% | -507,866 (-12.94%) | Filing |
| 2021-02-12 6:42 pm Purchase | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | FARALLON CAPITAL MANAGEMENT LLC | 3,925,000 9.000% | 1,071,902 (+37.57%) | Filing |
| 2020-02-14 06:19 am Purchase | 2019-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | FARALLON CAPITAL MANAGEMENT LLC | 2,853,098 9.900% | 471,998 (+19.82%) | Filing |